BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35691725)

  • 21. Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations.
    Otsuji K; Sasaki T; Tanabe M; Seto Y
    Br J Cancer; 2021 Jan; 124(2):466-473. PubMed ID: 33046803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant phyllodes tumor with EGFR variant III mutation: A rare case report with immunohistochemical and genomic studies.
    Kitazono I; Akahane T; Sasaki H; Ohi Y; Shinden Y; Takajo T; Tasaki T; Higashi M; Noguchi H; Hisaoka M; Tanimoto A
    Pathol Res Pract; 2024 Jul; 259():155389. PubMed ID: 38850845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases.
    Ng CC; Tan J; Ong CK; Lim WK; Rajasegaran V; Nasir ND; Lim JC; Thike AA; Salahuddin SA; Iqbal J; Busmanis I; Chong AP; Teh BT; Tan PH
    J Clin Pathol; 2015 Sep; 68(9):685-91. PubMed ID: 26018969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast.
    Piscuoglio S; Murray M; Fusco N; Marchiò C; Loo FL; Martelotto LG; Schultheis AM; Akram M; Weigelt B; Brogi E; Reis-Filho JS
    Histopathology; 2015 Nov; 67(5):719-29. PubMed ID: 25855048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
    Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
    BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast.
    Kim JY; Yu JH; Nam SJ; Kim SW; Lee SK; Park WY; Noh DY; Nam DH; Park YH; Han W; Lee JE
    Transl Oncol; 2018 Feb; 11(1):18-23. PubMed ID: 29145046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
    Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
    ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MED12 exon 2 mutations in phyllodes tumors of the breast.
    Nagasawa S; Maeda I; Fukuda T; Wu W; Hayami R; Kojima Y; Tsugawa K; Ohta T
    Cancer Med; 2015 Jul; 4(7):1117-21. PubMed ID: 25865354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent insights into the molecular pathogenesis of mammary phyllodes tumours.
    Karim RZ; O'Toole SA; Scolyer RA; Cooper CL; Chan B; Selinger C; Yu B; Carmalt H; Mak C; Tse GM; Tan PH; Putti TC; Lee CS
    J Clin Pathol; 2013 Jun; 66(6):496-505. PubMed ID: 23404800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers.
    Reinisch M; Kuemmel S; Breit E; Theuerkauf I; Harrach H; Schindowski D; Moka D; Bettstetter M; Bruzas S; Chiari O
    Orphanet J Rare Dis; 2021 Aug; 16(1):363. PubMed ID: 34399808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of pleomorphic liposarcomatous differentiation in malignant phyllodes tumor of the breast: A case report.
    Zhou P; Zhang Q; Zhu J; Li P
    Pathol Res Pract; 2021 Aug; 224():153489. PubMed ID: 34091389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast.
    Lien HC; Huang CS; Yang YW; Jeng YM
    APMIS; 2016 May; 124(5):356-64. PubMed ID: 26860948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
    Kleer CG; Giordano TJ; Braun T; Oberman HA
    Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.
    Geyer FC; Burke KA; Piscuoglio S; Ng CKY; Papanastasiou AD; Marchiò C; Selenica P; Edelweiss M; Murray MP; Brogi E; Soslow RA; Rubin BP; Norton L; Reis-Filho JS; Weigelt B
    Mol Oncol; 2017 Aug; 11(8):913-926. PubMed ID: 28267263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive genomic profiling of malignant phyllodes tumors of the breast.
    Nozad S; Sheehan CE; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Schrock AB; Hirshfield KM; Ali N; Ganesan S; Ali SM; Miller VA; Stephens PJ; Ross JS; Chung JH
    Breast Cancer Res Treat; 2017 Apr; 162(3):597-602. PubMed ID: 28210881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
    Di Liso E; Bottosso M; Lo Mele M; Tsvetkova V; Dieci MV; Miglietta F; Falci C; Faggioni G; Tasca G; Giorgi CA; Giarratano T; Mioranza E; Michieletto S; Saibene T; Dei Tos AP; Conte P; Guarneri V
    ESMO Open; 2020 Oct; 5(5):e000843. PubMed ID: 33020219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs are differentially deregulated in mammary malignant phyllodes tumour.
    Tsang JY; Ni YB; Ng EK; Shin VY; Mak KF; Go EM; Tawasil J; Chan SK; Ko CW; Kwong A; Tse GM
    Histopathology; 2015 Sep; 67(3):294-305. PubMed ID: 25585495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of mutation profile between primary phyllodes tumors of the breast and their paired local recurrences.
    Mitus J; Adamczyk A; Majchrzyk K; Kowalik A; Ryś J; Niemiec J
    Pol J Pathol; 2020; 71(1):7-12. PubMed ID: 32429649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant phyllodes tumour with lymph node metastasis: a diagnostic conundrum resolved by next generation DNA sequencing.
    Schwartz CJ; Krings G; Chen YY
    Histopathology; 2024 Jan; 84(2):409-411. PubMed ID: 37706238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor.
    Piscuoglio S; Geyer FC; Burke KA; Murray MP; Ng CK; Mota A; Marchio C; Berman SH; Norton L; Brogi E; Weigelt B; Reis-Filho JS
    NPJ Breast Cancer; 2016; 2():16035. PubMed ID: 28721388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.